FARIS, R., FLATHER, M., PURCELL, H., HENEIN, M., POOLE-WILSON, P. & COATS, A.

2002. Current evidence supporting the role of diuretics in heart failure: a meta analysis of
randomised controlled trials. International Journal of Cardiology, 82, 149-158.
KOELL, B., ZOTTER-TUFARO, C., DUCA, F., KAMMERLANDER, A. A., ASCHAUER, S.,
DALOS, D., ANTLANGER, M., HECKING, M., SÄEMANN, M., MASCHERBAUER,
J. & BONDERMAN, D. 2017. Fluid status and outcome in patients with heart failure and
preserved ejection fraction. International Journal of Cardiology, 230, 476-481.
MCMURRAY, J., COHEN SOLAL, A., DIETZ, R., EICHHORN, E., ERHARDT, L., HOBBS,
F. D. R., KRUM, H., MAGGIONI, A., MCKELVIE, R., PIÑA, I., SOLER SOLER, J. &
SWEDBERG, K. Practical recommendations for the use of ACE inhibitors, beta-
blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure:
putting guidelines into practice.
NAVIS, G., FABER, H. J., DE ZEEUW, D. & DE JONG, P. E. ACE inhibitors and the kidney. A
risk-benefit assessment.
SHIBATA, M. C., FLATHER, M. D. & WANG, D. Systematic review of the impact of beta
blockers on mortality and hospital admissions in heart failure.
YUSUF, S., SLEIGHT, P., POGUE, J., BOSCH, J., DAVIES, R. & DAGENAIS, G. Effects of an
angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk
patients. The Heart Outcomes Prevention Evaluation Study Investigators.